在日本急性中耳炎治疗期间影响抗菌变化的因素:使用分类和回归树 (CART) 分析的回顾性队列研究
Masamitsu Kono1, Daichi Murakami1, Hideki Sakatani1
1Department of Otorhinolaryngology Head and Neck Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama-shi, Wakayama, Wakayama, 641-8510, Japan.
概括
医院规模和患者登记史影响小儿急性中耳炎 (AOM) 的抗菌变化. 抗菌药物管理计划是促进适当AOM治疗的关键.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 适当的抗菌药物使用对于治疗儿科急性中耳炎 (AOM) 至关重要.
- 了解影响抗微生物治疗变化的因素对于优化AOM护理至关重要.
研究的目的:
- 调查影响小儿AOM第一线抗菌剂变化的因素.
- 促进在AOM治疗中适当使用抗菌药物.
主要方法:
- 使用电子医疗记录数据库进行描述性研究.
- 使用分类和回归树 (CART) 对16353名儿科AOM患者 (1996-2019) 的分析.
- 分析了14天内影响抗菌剂变化的因素.
主要成果:
- 设施大小 (床位数) 和病人的历史记录持续时间影响了抗菌药物变化.
- 分析了4860个单独的AOM病例和9567个伴随病症的AOM病例.
结论:
- 在全医院或全国范围内促进抗微生物药物管理显著影响抗微生物药物的变化.
- 准确的诊断和明确的治疗失败定义对于伴随疾病的AOM病例至关重要.
- 这项研究提供了洞察力,以加强在AOM管理中适当的抗菌药物利用.
相关概念视频
01:26Tonsillitis II: Management
110
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
110
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324